As a result, it has been reported that this interaction disrupts the PD-L1: PD-1 interaction and reduces the suppression of tumor-specific cytotoxic T cell activity induced by PD-L1 (Qiu et al., 2021). The gene discussed is CD274; the disease is neoplasm.